Neurodegenerative Disorders: Mechanisms of Degeneration and Therapeutic Approaches with Their Clinical Relevance.

Biomaterials Blood-brain barrier Cellular mechanisms of neurodegeneration Neurodegenerative disorders Novel therapeutic approaches

Journal

Ageing research reviews
ISSN: 1872-9649
Titre abrégé: Ageing Res Rev
Pays: England
ID NLM: 101128963

Informations de publication

Date de publication:
01 Jun 2024
Historique:
received: 01 03 2024
accepted: 27 05 2024
medline: 4 6 2024
pubmed: 4 6 2024
entrez: 3 6 2024
Statut: aheadofprint

Résumé

Neurodegenerative disorders (NDs) are expected to pose a significant challenge for both medicine and public health in the upcoming years due to global demographic changes. NDs are mainly represented by degeneration/loss of neurons, which is primarily accountable for severe mental illness. This neuronal degeneration leads to many neuropsychiatric problems and permanent disability in an individual. Moreover, the tight junction of the brain, blood-brain barrier (BBB)has a protective feature, functioning as a biological barrier that can prevent medicines, toxins, and foreign substances from entering the brain. However, delivering any medicinal agent to the brain in NDs (i.e., Multiple sclerosis, Alzheimer's, Parkinson's, etc.) is enormously challenging. There are many approved therapies to address NDs, but most of them only help treat the associated manifestations. The available therapies have failed to control the progression of NDs due to certain factors, i.e., BBB   and drug-associated undesirable effects. NDs have extremely complex pathology, with many pathogenic mechanisms involved in the initiation and progression; thereby, a limited survival rate has been observed in ND patients. Hence, understanding the exact mechanism behind NDs is crucial to developing alternative approaches for improving ND patients' survival rates. Thus, the present review sheds light on different cellular mechanisms involved in NDs and novel therapeutic approaches with their clinical relevance, which will assist researchers in developing alternate strategies to address the limitations of conventional ND therapies. The current work offers the scope into the near future to improve the therapeutic approach of NDs.

Identifiants

pubmed: 38830548
pii: S1568-1637(24)00175-2
doi: 10.1016/j.arr.2024.102357
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102357

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Dnyandev G Gadhave (DG)

Department of Pharmaceutics, Dattakala Shikshan Sanstha's, Dattakala College of Pharmacy (Affiliated to Savitribai Phule Pune University), Swami Chincholi, Daund, Pune 413130, Maharashtra, India; College of Pharmacy & Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, NY, 11439, USA.

Vrashabh V Sugandhi (VV)

Department of Pharmaceutics, Dattakala Shikshan Sanstha's, Dattakala College of Pharmacy (Affiliated to Savitribai Phule Pune University), Swami Chincholi, Daund, Pune 413130, Maharashtra, India; College of Pharmacy & Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, NY, 11439, USA.

Saurav Kumar Jha (SK)

Department of Biological Sciences and Bioengineering (BSBE), Indian Institute of Technology, Kanpur, 208016, Uttar Pradesh, India.

Sopan N Nangare (SN)

Department of Pharmaceutics, H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur: 425405, Dist- Dhule (MS), India.

Gaurav Gupta (G)

School of Pharmacy, Suresh Gyan Vihar University, Jagatpura 302017, Mahal Road, Jaipur, India; Centre for Transdisciplinary Research, Saveetha Institute of Medical and Technical Science, Saveetha University, Chennai, India; School of Pharmacy, Graphic Era Hill University, Dehradun 248007, India.

Sachin Kumar Singh (SK)

School of Pharmaceutical Sciences, Lovely Professional University, Phagwara-144411, India; School of Pharmacy, Graphic Era Hill University, Dehradun 248007, India.

Kamal Dua (K)

Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia.

Hyunah Cho (H)

College of Pharmacy & Health Sciences, St. John's University, 8000 Utopia Parkway, Queens, NY, 11439, USA; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia.

Philip M Hansbro (PM)

School of Pharmacy, Suresh Gyan Vihar University, Jagatpura 302017, Mahal Road, Jaipur, India; Centre for Inflammation, Faculty of Science, School of Life Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, Australia. Electronic address: Philip.hansbro@uts.edu.au.

Keshav Raj Paudel (KR)

School of Pharmacy, Suresh Gyan Vihar University, Jagatpura 302017, Mahal Road, Jaipur, India; Centre for Inflammation, Faculty of Science, School of Life Science, Centenary Institute and University of Technology Sydney, Sydney, 2007, Australia. Electronic address: Keshavraj.paudel@uts.edu.au.

Classifications MeSH